157518-70-2 Usage
Description
(2R)-4-METHYL-2-[(S)-2,2-DIMETHYL-5-OXO-1,3-DIOXOLAN-4-YL]VALERIC ACID is a chiral molecule with a molecular formula of C12H20O5. It is a derivative of valeric acid, featuring a dioxolane ring and a stereocenter at the second carbon atom. (2R)-4-METHYL-2-[(S)-2,2-DIMETHYL-5-OXO-1,3-DIOXOLAN-4-YL]VALERIC ACID is utilized in the pharmaceutical industry as a key building block for the synthesis of a variety of drugs, particularly those with antiviral and antifungal properties. Its potential biological and pharmacological activities make it a valuable subject of interest in medicinal chemistry research.
Used in Pharmaceutical Industry:
(2R)-4-METHYL-2-[(S)-2,2-DIMETHYL-5-OXO-1,3-DIOXOLAN-4-YL]VALERIC ACID is used as a building block for the synthesis of various drugs due to its unique structural features and chiral properties. It plays a crucial role in the development of antiviral and antifungal agents, contributing to the creation of effective medications to combat viral and fungal infections.
Used in Medicinal Chemistry Research:
In the field of medicinal chemistry, (2R)-4-METHYL-2-[(S)-2,2-DIMETHYL-5-OXO-1,3-DIOXOLAN-4-YL]VALERIC ACID is used for exploring its potential biological and pharmacological activities. Researchers investigate its interactions with biological targets and its capacity to modulate specific pathways, which can lead to the discovery of new therapeutic agents and a deeper understanding of its mechanisms of action.
Check Digit Verification of cas no
The CAS Registry Mumber 157518-70-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,5,7,5,1 and 8 respectively; the second part has 2 digits, 7 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 157518-70:
(8*1)+(7*5)+(6*7)+(5*5)+(4*1)+(3*8)+(2*7)+(1*0)=152
152 % 10 = 2
So 157518-70-2 is a valid CAS Registry Number.
157518-70-2Relevant articles and documents
METALLOPROTEINASE INHIBITORS
-
Page 24, (2010/02/09)
Compounds formula (IA) or (IB); wherein W represents HO(C=0)-, HONH(C=0)- or H(C=O)N(OH)-; X represents -O- or -S-; and R1, R2, and R3 are as defined in the description and claims, are inhibitors of matrix metalloproteinases, in particular MMP9 and/or MMP12.
